DFEOX
Price
$38.81
Change
+$0.16 (+0.41%)
Updated
Apr 17 closing price
Net Assets
31.17B
VITSX
Price
$125.99
Change
+$0.29 (+0.23%)
Updated
Apr 17 closing price
Net Assets
1.7T
Ad is loading...

DFEOX vs VITSX

Header iconDFEOX vs VITSX Comparison
Open Charts DFEOX vs VITSXBanner chart's image
DFA US Core Equity 1 I
Price$38.81
Change+$0.16 (+0.41%)
VolumeN/A
Net Assets31.17B
Vanguard Total Stock Market Idx I
Price$125.99
Change+$0.29 (+0.23%)
VolumeN/A
Net Assets1.7T
DFEOX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFEOX vs. VITSX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFEOX is a Buy and VITSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.7T vs. DFEOX (31.2B). VITSX pays higher dividends than DFEOX: VITSX (1.36) vs DFEOX (1.20). DFEOX was incepted earlier than VITSX: DFEOX (20 years) vs VITSX (28 years). DFEOX (0.15) is less costly to investors than VITSX (0.03). DFEOX is a more actively managed with annual turnover of: 6.00 vs. VITSX (2.00). DFEOX has a lower initial minimum investment than VITSX: DFEOX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 4.59 vs. DFEOX (4.07). DFEOX return over 5 years is better than : 88.06 vs. VITSX (81.38).
DFEOXVITSXDFEOX / VITSX
Total Expense Ratio0.150.03500%
Annual Report Gross Expense Ratio0.150.03500%
Fund Existence20 years28 years-
Gain YTD-9.988-10.64994%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.2B1.7T2%
Annual Yield % from dividends1.201.3688%
Returns for 1 year4.074.5989%
Returns for 3 years18.0017.82101%
Returns for 5 years88.0681.38108%
Returns for 10 years119.85146.7282%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTNT0.450.05
+13.67%
Xtant Medical Holdings
PMCB1.190.04
+3.48%
PharmaCyte Biotech
SWK57.210.40
+0.70%
Stanley Black & Decker
FLYW8.880.05
+0.57%
Flywire Corp
HCKT25.86-0.17
-0.65%
Hackett Group